Quantifying antihypertensive effects of GLP-1 agonists

Eur Heart J. 2024 Oct 7;45(38):4135-4137. doi: 10.1093/eurheartj/ehae520.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents* / therapeutic use
  • Blood Pressure / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy
  • Glucagon-Like Peptide 1* / agonists
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Humans
  • Hypertension* / drug therapy
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use

Substances

  • Antihypertensive Agents
  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists